* BIO-Key International Inc BKYI.OQ reported a quarterly
adjusted loss of 12 cents per share for the quarter ended in
March. The lone analyst forecast for the quarter was for a loss
of 22 cents per share.
* Revenue rose 2.8% to $1.94 million from a year ago;
analysts
expected $1.25 million.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* BIO-Key International Inc shares had fallen by 16.3% this
quarter and lost 9.0% so far this year.
* The company reported a quarterly loss of $999 thousand.
* Wall Street's median 12-month price target for BIO-Key
International Inc is $5.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated May 16 at 01:32 p.m. All
figures in US dollars unless otherwise stated